Therese Torngren
Medicon Village
Lund, M 22381, Sweden
Lund, M 22381, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Germline Pathogenic Variants in Breast Cancer-Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia.
Journal: JCO global oncology
Published: May 15, 2026
Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer.
Journal: Breast cancer research : BCR
Published: February 02, 2025
Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Journal: Scientific reports
Published: September 15, 2023
Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Journal: Scientific reports
Published: November 01, 2022
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Journal: Human mutation
Published: November 12, 2021
Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing.
Journal: Cancers
Published: September 20, 2021
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Journal: The New England journal of medicine
Published: January 20, 2021
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
Journal: Nature communications
Published: April 03, 2020
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.
Journal: Cancers
Published: December 13, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Journal: Human mutation
Published: January 30, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
Journal: JCO precision oncology
Published: January 01, 2018
Last Updated: 09/26/2026